{"preliminary_commentary":{"by_channel":{"x_thread":91,"youtube":11,"podcast":8,"bluesky_thread":4},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT02364557\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's free public preview; the full report is still bought."},"commentary_summary":null,"name":"NRG-BR002","nct_id":"NCT02364557","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=nrg-br002-nct02364557. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1950,"size":"deep","size_rule":"Deep: 301+ verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":"Standard of care systemic therapy at the discretion of the treating physician.","label":"Standard of Care (SOC)","type":"NO_INTERVENTION"},{"description":"Standard of care systemic therapy plus ablation of all metastases by stereotactic body radiotherapy or surgery at the discretion of the treating physician.","label":"Standard of Care + Ablation","type":"EXPERIMENTAL"}],"collaborators":["National Cancer Institute (NCI)"],"completion_date":{"date":"2025-09-04","type":"ACTUAL"},"conditions":["Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8","Metastatic Breast Carcinoma","Metastatic Malignant Neoplasm in the Bone","Metastatic Malignant Neoplasm in the Liver","Metastatic Malignant Neoplasm in the Lung","Metastatic Malignant Neoplasm in the Lymph Nodes","Metastatic Malignant Neoplasm in the Spine","Prognostic Stage IV Breast Cancer AJCC v8","Anatomic Stage IV Breast Cancer AJCC v8"],"enrollment":{"count":129,"type":"ACTUAL"},"has_results":true,"interventions":[{"name":"Stereotactic Body Radiotherapy","otherNames":["Stereotactic External Beam Irradiation","stereotactic external-beam radiation therapy","Stereotactic Radiation Therapy","Stereotactic Radiosurgery","Stereotactic Radiotherapy","stereotaxic radiation therapy","stereotaxic radiosurgery","SBRT","stereotactic ablative radiotherapy (SABR)"],"type":"RADIATION"},{"name":"Surgery","otherNames":[],"type":"PROCEDURE"}],"last_update":"2026-07-10","lead_sponsor":"NRG Oncology","official_title":"A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer","overall_status":"COMPLETED","phases":["PHASE2","PHASE3"],"primary_completion_date":{"date":"2021-12-20","type":"ACTUAL"},"primary_outcomes":[{"measure":"Progression-free Survival (Phase II)","timeFrame":"From randomization to last follow-up. Follow-up schedule: 3 mos after randomization and every 3 months to 24 months, then every six months to five years, then annually. Maximum follow-up at time of analysis was 63 months."},{"measure":"Overall Survival (Phase III)","timeFrame":"From randomization to last follow-up. Follow-up schedule: 3 mos after randomization and every 3 months to 24 months and then annually. Maximum follow-up at time of analysis was 63 months."}],"references":[{"citation":"Petrelli F, Ghidini A, Ghidini M, Bukovec R, Trevisan F, Turati L, Indini A, Seghezzi S, Lonati V, Moleri G, Tomasello G, Zaniboni A. Better survival of patients with oligo- compared with polymetastatic cancers: a systematic review and meta-analysis of 173 studies. F1000Res. 2021 May 27;10:423. doi: 10.12688/f1000research.52546.4. eCollection 2021.","pmid":"35602670","type":"DERIVED"}],"start_date":{"date":"2014-12-24","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival","url":"https://clinicaltrials.gov/study/NCT02364557"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/nrg-br002-nct02364557"}